Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study

Annals of Oncology · Elsevier

Аннотация

Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): J. Bedke, P. Arkosy, H. Nishiyama, H. Mahammedi, C. Vulsteke, M.J. Juan-Fita, I. Antonyan, O. Didas, E. Verzoni, V. Atduev, A. Rodriguez-Vida, J.J. Oh, S.-H. Kang, A. Peer, R. Zukov, B. Zurawksi, M. Gümüş, G.D. Steinberg, J. Olah, S. Abadie-Lacourtoisie

Читать у издателя →

Похожие статьи